Adults, including the elderly (>65 years): For the induction and maintenance of clinical and endoscopic remission in patients with mild to moderate, active ulcerative colitis.
Children and adolescents (weighing more than 50 kg and age 10 years or older): For the induction and maintenance of clinical and endoscopic remission in patients with mild to moderate, active ulcerative colitis.